Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−69.94 M USD
0.00 USD
37.95 M
About Achilles Therapeutics plc
Sector
CEO
Iraj Ali
Headquarters
London
Website
Founded
2020
FIGI
BBG00ZHF9VV8
Achilles Therapeutics Plc is a biopharmaceutical company engaged in developing transformative precision T-cell therapies to treat multiple types of solid tumors. It focuses on researching, developing and commercializing potentially novel cancer immunotherapies targeting clonal neoantigens. The company was founded by Karl Peggs, Sergio Quezada, Mark Lowdell and Charles Swanton in November 2020 and is headquartered in London, the United Kingdom.
Displays a symbol's price movements over previous years to identify recurring trends.